We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our privacy policy and for us to access our cookies on your device.
Title:Sanofi to Buy Principia Biopharma in $3.4 Billion Deal
Date:17th August 2020
Description:Aug.17 -- Sanofi has agreed to acquire Principia Biopharma Inc. in a $3.4 billion deal. The move comes as the French drug maker pivots toward innovative therapies to spur growth. The all-cash deal will see Sanofi taking full control of the U.S. autoimmune drug maker. Bloomberg’s James Paton reports on “Bloomberg Markets: European Open.”
